Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice

Figure 1

Kaplan–Meier curve analysis for all-cause and cardiovascular (CV) mortality in patients with and without ≥50% reduced LDL-C levels during the 3-yearfollow-up period. (a) During the 3-yearfollow-up period, a higher incidence of all-cause mortality was noted in patients without ≥50% reduced LDL-C levels (with vs. without; 1-year: 4.4% vs. 6.2%; ; 2-year: 9.3% vs. 11.9%; ; 3-year: 11.9% vs. 16.4%; ). (b) During the 3-year follow-up period, a higher incidence of CV mortality was noted in patients without ≥50% reduction in LDL-C levels (with vs. without; 1-year: 1.8% vs. 2.4%; ; 2-year: 3.5% vs. 4.2%; ; 3-year: 4.3% vs. 5.5%; ).

(a)

(b)